secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0000950170-24-017875
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma signs $25M ATM equity facility, initially capped at $10.3M due to float limit
--------------------------------------------------------------------------------

- Entered into Capital on Demand Sales Agreement with JonesTrading to sell up to $25M of common stock in ATM offerings.
- Initial offering limit is $10.3M because public float is under $75M; may increase if float grows.
- Also filed a universal Form S-3 registration statement for up to $100M in securities.
- Agent commission is 3.0% of gross proceeds from shares sold under the agreement.
- No assurance any shares will be issued; agreement can be terminated by either party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000095017024017875/0000950170-24-017875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000095017024017875/meip-20240221.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-017875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer